Jazz Pharmaceuticals Plc (JAZZ)
250.68
+6.14
(+2.51%)
USD |
NASDAQ |
Aug 31, 16:00
250.50
-0.18
(-0.07%)
After-Hours: 20:00
Jazz Pharmaceuticals Total Long Term Debt (Quarterly) : 4.395B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.395B |
| March 31, 2026 | 5.402B |
| December 31, 2025 | 5.413B |
| September 30, 2025 | 5.415B |
| June 30, 2025 | 5.419B |
| March 31, 2025 | 5.406B |
| December 31, 2024 | 6.153B |
| September 30, 2024 | 6.183B |
| June 30, 2024 | 5.774B |
| March 31, 2024 | 5.767B |
| December 31, 2023 | 5.778B |
| September 30, 2023 | 5.777B |
| June 30, 2023 | 5.783B |
| March 31, 2023 | 5.793B |
| December 31, 2022 | 5.801B |
| September 30, 2022 | 5.800B |
| June 30, 2022 | 6.099B |
| March 31, 2022 | 6.107B |
| December 31, 2021 | 6.144B |
| September 30, 2021 | 6.374B |
| June 30, 2021 | 6.901B |
| March 31, 2021 | 2.238B |
| December 31, 2020 | 2.235B |
| September 30, 2020 | 2.230B |
| June 30, 2020 | 2.247B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.757B |
| December 31, 2019 | 1.758B |
| September 30, 2019 | 1.758B |
| June 30, 2019 | 1.758B |
| March 31, 2019 | 1.753B |
| December 31, 2018 | 1.596B |
| September 30, 2018 | 1.594B |
| June 30, 2018 | 1.592B |
| March 31, 2018 | 1.582B |
| December 31, 2017 | 1.581B |
| September 30, 2017 | 1.580B |
| June 30, 2017 | 1.672B |
| March 31, 2017 | 1.876B |
| December 31, 2016 | 2.030B |
| September 30, 2016 | 2.183B |
| June 30, 2016 | 1.179B |
| March 31, 2016 | 1.184B |
| December 31, 2015 | 1.188B |
| September 30, 2015 | 1.290B |
| June 30, 2015 | 1.366B |
| March 31, 2015 | 1.344B |
| December 31, 2014 | 1.342B |
| September 30, 2014 | 1.341B |
| June 30, 2014 | 1.196B |
| March 31, 2014 | 1.199B |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| Perrigo Co. Plc | 3.433B |
| GH Research Plc | 0.36M |
| Cosmo NV | 0.00 |
| Axsome Therapeutics, Inc. | 154.05M |